Does Tracey Marks recommend Inositol?
Tracey Marks recommends Inositol in some contexts, but has also raised cautions.
Published research rates it weak evidence. Of Tracey Marks's 96 tracked claims, 22 are supported or partially supported by studies on PubMed.
Evidence last reviewed May 2026
Tracey Marks on Inositol — 96 claims
“the practical implication is that you need a bulk powder form, not capsules, to achieve them cost-effectively.”
To achieve psychiatric research doses cost-effectively, a bulk powder form is needed rather than capsules.
None of the 10 provided studies address the specific claim that bulk powder forms of supplements are necessary to achieve psychiatric research doses cost-effectively compared to capsules. The studies…
“For patients who have tried SSRIs and had poor tolerability, or who are looking for an adjunctive option, inositol is worth a serious conversation.”
For patients who have tried SSRIs with poor tolerability, or who are looking for an adjunctive option, inositol is worth a serious conversation.
The expert's claim specifically concerns inositol as an SSRI alternative or adjunct for psychiatric indications (implying depression or anxiety), but none of the 10 provided studies directly address t…
“For patients who have tried SSRIs and had poor tolerability, or who are looking for an adjunctive option, inositol is worth a serious conversation.”
For patients who have tried SSRIs with poor tolerability, or who are looking for an adjunctive option, inositol is worth a serious conversation.
The expert claim specifically concerns inositol as an alternative or adjunctive option for patients with poor SSRI tolerability in psychiatric contexts (implying depression or anxiety). None of the 10…
“the practical implication is that you need a bulk powder form, not capsules, to achieve them cost-effectively.”
To achieve psychiatric research doses cost-effectively, a bulk powder form is needed rather than capsules.
None of the 10 provided studies address the claim that bulk powder form is necessary or more cost-effective than capsules for achieving psychiatric research doses of any supplement. The studies cover…
“the practical implication is that you need a bulk powder form, not capsules, to achieve them cost-effectively.”
To achieve psychiatric research doses cost-effectively, a bulk powder form is needed rather than capsules.
None of the 10 published research studies provided address the practical or economic claim that bulk powder form is necessary to achieve psychiatric research doses cost-effectively. The claim is funda…
“For patients who have tried SSRIs and had poor tolerability, or who are looking for an adjunctive option, inositol is worth a serious conversation.”
For patients who have tried SSRIs with poor tolerability, or who are looking for an adjunctive option, inositol is worth a serious conversation.
The expert claim concerns inositol as a psychiatric adjunct or SSRI alternative for mood/anxiety disorders. While the WFSBP/CANMAT nutraceutical guidelines (PMID 35311615) are directly relevant to psy…
“the practical implication is that you need a bulk powder form, not capsules, to achieve them cost-effectively.”
To achieve psychiatric research doses cost-effectively, a bulk powder form is needed rather than capsules.
None of the 10 provided studies address the practical question of supplement formulation (bulk powder vs. capsules) or cost-effectiveness for achieving psychiatric research doses. The claim is logisti…
“For patients who have tried SSRIs and had poor tolerability, or who are looking for an adjunctive option, inositol is worth a serious conversation.”
For patients who have tried SSRIs with poor tolerability, or who are looking for an adjunctive option, inositol is worth a serious conversation.
The expert's claim concerns inositol as a psychiatric adjunct or SSRI alternative for patients with poor tolerability, but none of the 10 provided studies directly address this psychiatric use case. T…
“the practical implication is that you need a bulk powder form, not capsules, to achieve them cost-effectively.”
To achieve psychiatric research doses cost-effectively, a bulk powder form is needed rather than capsules.
None of the 10 provided studies address the practical question of whether bulk powder form is necessary to achieve psychiatric research doses cost-effectively compared to capsules. The claim is a prag…
“For patients who have tried SSRIs and had poor tolerability, or who are looking for an adjunctive option, inositol is worth a serious conversation.”
For patients who have tried SSRIs with poor tolerability, or who are looking for an adjunctive option, inositol is worth a serious conversation.
The expert's claim specifically addresses inositol as an alternative or adjunct to SSRIs for psychiatric indications (implying mood/anxiety disorders), but none of the 10 provided studies directly eva…
“the practical implication is that you need a bulk powder form, not capsules, to achieve them cost-effectively.”
To achieve psychiatric research doses cost-effectively, a bulk powder form is needed rather than capsules.
None of the 10 published studies listed address the practical or economic question of whether bulk powder versus capsule formulations are needed to achieve psychiatric research doses cost-effectively.…
“For patients who have tried SSRIs and had poor tolerability, or who are looking for an adjunctive option, inositol is worth a serious conversation.”
For patients who have tried SSRIs with poor tolerability, or who are looking for an adjunctive option, inositol is worth a serious conversation.
The expert's claim specifically concerns inositol as an adjunctive or alternative option for patients with poor SSRI tolerability in a psychiatric context. While the WFSBP/CANMAT meta-analysis (PMID:…
“For depression, the results have been more mixed — some positive signals but also null findings in larger samples.”
For depression, results with inositol have been mixed — some positive signals but also null findings in larger samples.
None of the 10 retrieved studies directly address inositol's effects on depression. The available literature focuses predominantly on PCOS, fertility, gestational diabetes, thyroid disorders, and bipo…
“Here the doses studied are lower, typically 2 to 4 grams of myo-inositol per day, sometimes combined with D-chiro-inositol in a 40:1 ratio.”
For PCOS, myo-inositol is studied at lower doses, typically 2 to 4 grams per day, sometimes combined with D-chiro-inositol in a 40:1 ratio.
The expert's claim regarding myo-inositol dosing (2–4 g/day) and the 40:1 myo-inositol to D-chiro-inositol ratio for PCOS is consistent with widely cited clinical practice and aligns with the general…
“The evidence for myo-inositol improving insulin sensitivity, restoring ovulatory function, and improving metabolic markers in PCOS is reasonably consistent across multiple trials.”
The evidence for myo-inositol improving insulin sensitivity, restoring ovulatory function, and improving metabolic markers in PCOS is reasonably consistent across multiple trials.
The provided research corpus includes multiple relevant study types (systematic reviews, meta-analyses, and narrative reviews) covering myo-inositol in PCOS and metabolic conditions, including a stron…
“This is probably the strongest evidence base for inositol right now.”
The evidence base for inositol in PCOS is probably the strongest currently available for this supplement.
The claim that inositol has the strongest evidence base among supplements for PCOS is plausible given the research landscape, but the provided studies do not directly confirm this comparative superior…
“myo-inositol, which is the form that's been studied most in psychiatric contexts”
Myo-inositol is the form of inositol most studied in psychiatric contexts.
None of the 10 provided studies directly address the comparative research volume of myo-inositol versus other inositol forms in psychiatric contexts. The available literature is predominantly focused…
“For OCD, a similar pilot study showed improvement comparable to SSRIs on the Y-BOCS scale at 18 grams per day.”
A pilot study showed inositol at 18 grams per day improved OCD symptoms comparably to SSRIs on the Y-BOCS scale.
None of the 10 provided research documents address inositol's effects on OCD or compare it to SSRIs on the Y-BOCS scale. The studies retrieved focus predominantly on PCOS, fertility, gestational diabe…
“For OCD, a similar pilot study showed improvement comparable to SSRIs on the Y-BOCS scale at 18 grams per day.”
A pilot study showed inositol at 18 grams per day improved OCD symptoms comparably to SSRIs on the Y-BOCS scale.
None of the 10 published research articles provided address inositol's use for OCD or its comparison to SSRIs on the Y-BOCS scale. The available literature focuses on inositol in the context of PCOS,…
“For depression, the results have been more mixed — some positive signals but also null findings in larger samples.”
For depression, results with inositol have been mixed — some positive signals but also null findings in larger samples.
None of the 10 provided studies directly examine inositol for depression. The closest relevant study (PMID: 35311615) is a WFSBP/CANMAT meta-analysis on nutraceuticals for psychiatric disorders, which…
Other supplements Tracey Marks discusses
Claims are extracted from publicly available podcasts and videos, attributed to their source, and compared against PubMed research. This is educational information only — consult a healthcare provider before starting any supplement.
Back to Tracey Marks